Abstract
This paper aims to outline China's pharmaceutical market with a focus on the changing health consumer. Currently, the Chinese population numbers 1.3 billion and estimates suggest 25 per cent of the population will be aged over 60 by 2050. Moreover, trends toward higher living standards and urbanisation are increasing and there is a growing movement toward lifestyle medication, self-medication, buying drugs online and ‘modern’ medicine — the use of traditional Chinese medicine is decreasing gradually. Keeping close track of these trends will provide the best opportunity of investing effectively in China.
Get full access to this article
View all access options for this article.
